<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: pharmaceutical companies</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Drug industry presses FDA to allow more online ads</title>
   	 <description>(AP) --  As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.</description>
     <link>http://www.physorg.com/news177165326.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 11 Nov 2009 12:50:03 EST</pubDate>
	 <guid isPermaLink="false">news177165326</guid>
</item>
<item>
     <title>Study Suggests Affordable Vaccines Within Reach</title>
   	 <description>(PhysOrg.com) -- A new research paper suggests that pharmaceutical companies can afford to produce less expensive vaccines for lower-income countries because the companies can recover their research and development (R&amp;D) costs through the sale of the vaccine to higher-priced markets. The findings are included in an article co-authored by University of Victoria health economist Rebecca Warburton being published this week in the journal Vaccine.</description>
     <link>http://www.physorg.com/news176456892.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 03 Nov 2009 07:48:50 EST</pubDate>
	 <guid isPermaLink="false">news176456892</guid>
</item>
<item>
     <title>Patent challenges reduce pharmaceutical innovation and productivity, researchers say</title>
   	 <description>The development of new and innovative pharmaceuticals is being stifled by a U.S. law and successful patent challenges that embolden generic competition, according to an article published in this week's issue of the journal Science.</description>
     <link>http://www.physorg.com/news174837810.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 15 Oct 2009 16:40:08 EST</pubDate>
	 <guid isPermaLink="false">news174837810</guid>
</item>
<item>
     <title>Sanofi to deliver swine flu vaccine in October</title>
   	 <description>(AP) --  Sanofi-Aventis SA will begin delivering the first doses of its new swine flu vaccine in the United States by mid-October, the head of France's largest pharmaceutical company said Monday.</description>
     <link>http://www.physorg.com/news172761706.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Sep 2009 14:40:02 EST</pubDate>
	 <guid isPermaLink="false">news172761706</guid>
</item>
<item>
     <title>WHO predicts 'explosion' of swine flu cases</title>
   	 <description>(AP) --  The global spread of swine flu will endanger more lives as it speeds up in coming months and governments must boost preparations for a swift response, the World Health Organization said Friday.</description>
     <link>http://www.physorg.com/news170053663.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 21 Aug 2009 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news170053663</guid>
</item>
<item>
     <title>Project Zero Delay accelerates drug's path to clinical trial</title>
   	 <description>A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3rd.</description>
     <link>http://www.physorg.com/news168538136.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 17:09:18 EST</pubDate>
	 <guid isPermaLink="false">news168538136</guid>
</item>
<item>
     <title>Australia starts 1st swine flu vaccine trials</title>
   	 <description>(AP) --  The world's first human trials of a swine flu vaccine have begun in Australia, drug company officials said Wednesday, with the aim of controlling the virus that has so far killed more than 700 worldwide.</description>
     <link>http://www.physorg.com/news167402541.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Jul 2009 05:38:33 EST</pubDate>
	 <guid isPermaLink="false">news167402541</guid>
</item>
<item>
     <title>Fight for swine flu vaccine could get ugly</title>
   	 <description>(AP) --  An ugly scramble is brewing over the swine flu vaccine - and when it becomes available, Britain, the United States and other nations could find that the contracts they signed with pharmaceutical companies are easily broken.</description>
     <link>http://www.physorg.com/news166975121.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Jul 2009 15:10:03 EST</pubDate>
	 <guid isPermaLink="false">news166975121</guid>
</item>
<item>
     <title>WHO: No swine flu vaccine available for months (Update)</title>
   	 <description>(AP) --  Drug manufacturers won't be able to start making a swine flu vaccine until mid-July at the earliest, weeks later than previous predictions, the World Health Organization said Tuesday. It will then take months to produce a new vaccine.</description>
     <link>http://www.physorg.com/news161935741.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 19 May 2009 07:18:35 EST</pubDate>
	 <guid isPermaLink="false">news161935741</guid>
</item>
<item>
     <title>WHO eyes swine flu transmision rates, new vaccine</title>
   	 <description>(AP) --  Health experts are looking very closely at the spread of swine flu among people in Spain, Britain and Japan, a WHO official said Sunday as Japan reported a one-day explosion of over 70 new cases, mostly among teenagers.</description>
     <link>http://www.physorg.com/news161786401.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 17 May 2009 13:40:35 EST</pubDate>
	 <guid isPermaLink="false">news161786401</guid>
</item>
<item>
     <title>New fund promises low-cost malaria treatment</title>
   	 <description>(AP) --  A $225 million fund to provide low-price anti-malaria medicine around the world was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day.</description>
     <link>http://www.physorg.com/news159342410.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 19 Apr 2009 06:48:53 EST</pubDate>
	 <guid isPermaLink="false">news159342410</guid>
</item>
<item>
     <title>Nurse practitioners don't realise how much their prescribing is being influenced by drug marketing</title>
   	 <description>Family nurse practitioners need to be more aware of the commercial pressures they face as a result of their increased involvement in prescribing, according to a survey published in the March issue of the UK-based Journal of Advanced Nursing.</description>
     <link>http://www.physorg.com/news155893429.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 10 Mar 2009 08:45:30 EST</pubDate>
	 <guid isPermaLink="false">news155893429</guid>
</item>
<item>
     <title>Researchers: Strengthen restrictions on off-label promotion by pharmaceutical companies</title>
   	 <description>Researchers are asking for tougher penalties and fines for pharmaceutical companies that market drugs for "off label" promotion, according to a study published in the October 28 issue of the open access journal PLoS Medicine.</description>
     <link>http://www.physorg.com/news144397931.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Oct 2008 07:32:11 EST</pubDate>
	 <guid isPermaLink="false">news144397931</guid>
</item>
<item>
     <title>Candy-coating keeps proteins sweet</title>
   	 <description>Sugar-frosting isn`t just for livening up boring bran flakes; it can also preserve important therapeutic proteins. Researchers at the National Institute of Standards and Technology have developed a fast, inexpensive and effective method for evaluating the sugars pharmaceutical companies use to stabilize protein-drugs for storage at room temperature. The group presented their findings at the 236th American Chemical Society National Meeting and Exposition.</description>
     <link>http://www.physorg.com/news138385579.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 19 Aug 2008 17:26:19 EST</pubDate>
	 <guid isPermaLink="false">news138385579</guid>
</item>


</channel>
</rss>

